Transgenomic Announces $4.5 Million Private Placement

Aug 28, 2003

NEW YORK, Aug. 28 (GenomeWeb News) - Transgenomic said today that it has signed securities purchase deals worth a total of $4.5 million with a number of select investors.

The Omaha, Neb.-based company said that the biggest purchasers were two of its largest institutional investors.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Breaking News

The Scan

NIH's Collins on Harassment

In a statement, National Institutes of Health Director Francis Collins says sexual harassment is "morally indefensible" and "unacceptable."

With Eight Arms and Giant Eyes

Octopuses might owe their intelligence to their liberal alterations to their genes, Cosmos reports.

Missing From Trials

Stat News and ProPublica report that African Americans are underrepresented in cancer clinical trials.

This Week in Cell

In Cell this week: genomic analysis of abdominal aortic aneurysm, effect of probiotics on the microbiome, and more.

Main menu